眼内高浓度纤维蛋白原通过ICAM-1通路调控视网膜功能
该研究在正常小鼠玻璃体内注射纤维蛋白原,观察到神经元标志物TUBB3表达下降及视网膜电图正相暗视阈值反应和b波振幅降低,提示视网膜神经节细胞潜在损伤;联合抗ICAM-1抗体可减轻上述改变,表明纤维蛋白原损伤经由ICAM-1通路介导。
要点
- 玻璃体内注射40 mg/mL纤维蛋白原可降低小鼠视网膜TUBB3表达并减小正相暗视阈值反应和b波振幅。
- 联合抗ICAM-1抗体可减轻纤维蛋白原引起的上述视网膜功能与标志物改变。
- 作者认为眼内纤维蛋白原升高是糖尿病视网膜病变的致病因素,纤维蛋白原/ICAM-1通路提供治疗干预新途径。
核心结论
- 眼内纤维蛋白原水平升高是糖尿病视网膜病变的致病因素,纤维蛋白原/ICAM-1通路为治疗干预提供新途径,尤其对治疗抵抗的患者。
研究设计与样本
- 在正常小鼠中玻璃体内注射1×磷酸盐缓冲液、40 mg/mL纤维蛋白原、40 mg/mL纤维蛋白原联合抗ICAM-1抗体,采用免疫荧光、蛋白质印迹和视网膜电图观察。
主要发现
- 高浓度纤维蛋白原导致免疫荧光和蛋白质印迹中TUBB3表达下降。
- 注射纤维蛋白原后正相暗视阈值反应和b波振幅显著降低,提示视网膜神经节细胞潜在损伤。
- 联合抗ICAM-1抗体有效减轻纤维蛋白原诱导的上述改变,表明损伤经由ICAM-1通路介导。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Diabetic retinopathy (DR) is a significant complication of diabetes mellitus that can lead to progressive visual impairment. This study aimed to elucidate the role of fibrinogen, a protein whose serum and intraocular concentrations are elevated in patients with diabetes and DR, in the pathogenesis of DR. METHODS: The changes in the protein levels of the neuronal marker tubulin-β3 (TUBB3) and retinal response induced by the intravitreal injections of 1× phosphate-buffered saline, 40 mg/mL of fibrinogen, and 40 mg/mL of fibrinogen in combination with anti-intracellular adhesion molecule-1 (ICAM-1) antibody in normal mice were observed using immunofluorescence, western blotting, and electroretinography. RESULTS: High concentrations of fibrinogen led to a decrease in the expression of TUBB3 in immunofluorescence and western blotting. The amplitudes of the positive scotopic threshold response and b-wave were notably reduced after the injection of fibrinogen, indicating potential damage to the retinal ganglion cells. The co-administration of anti-ICAM-1 antibody effectively mitigated these fibrinogen-induced changes, indicating that fibrinogen-induced damage is mediated via the ICAM-1 pathway. CONCLUSIONS: The present study underscores the significance of elevated intraocular fibrinogen levels as a pathogenic factor in DR. Involvement of the fibrinogen/ICAM-1 pathway presents new avenues for therapeutic intervention, especially in patients with treatment-resistant conditions.
引用
- Sotani Y, Imai H, Yamada H, et al. High Intraocular Concentration of Fibrinogen Regulates Retinal Function Via the ICAM-1 Pathway. Invest Ophthalmol Vis Sci. 2024. PMID: 39546292. doi:10.1167/iovs.65.13.34
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。